ICAD SEC Filings

Type
Report
Date
SCHEDULE 13GSCHEDULE 13G-Formular8/12/2025
15-12G15-12G-Formular7/28/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
EFFECTEFFECT-Formular7/21/2025
4Insidertransaktion7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/17/2025
4Insidertransaktion7/17/2025
4Insidertransaktion7/17/2025
4Insidertransaktion7/17/2025
4Insidertransaktion7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
4Insidertransaktion7/17/2025
POS AMPOS AM-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
25-NSE25-NSE-Formular7/17/2025
4Insidertransaktion7/17/2025
4Insidertransaktion7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
S-8 POSS-8 POS-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
POS AMPOS AM-Formular7/17/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/14/2025
425425-Formular7/8/2025
DEFA14ADEFA14A-Formular7/2/2025
425425-Formular7/1/2025
425425-Formular6/16/2025
425425-Formular5/22/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/22/2025
DEFM14ADEFM14A-Formular5/21/2025
425425-Formular5/13/2025
10-QQuartalsbericht5/13/2025
425425-Formular5/13/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/13/2025
10-K/A10-K/A-Formular4/30/2025
425425-Formular4/29/2025
425425-Formular4/29/2025
425425-Formular4/29/2025
425425-Formular4/24/2025
425425-Formular4/24/2025
425425-Formular4/23/2025
425425-Formular4/17/2025
425425-Formular4/17/2025
425425-Formular4/17/2025
425425-Formular4/17/2025
4Insidertransaktion4/16/2025
4Insidertransaktion4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/16/2025
425425-Formular4/15/2025
425425-Formular4/15/2025
425425-Formular4/15/2025
425425-Formular4/15/2025
425425-Formular4/15/2025
425425-Formular4/15/2025
425425-Formular4/15/2025
425425-Formular4/15/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/15/2025
10-KJahresbericht3/31/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/19/2025
4Insidertransaktion2/27/2025
4Insidertransaktion2/27/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/27/2025
4Insidertransaktion1/7/2025
4Insidertransaktion1/7/2025
4Insidertransaktion1/7/2025
4Insidertransaktion1/7/2025

ICAD Documents 2026

This page contains all official documents and SEC filings for ICAD stock (ICAD, ISIN: US44934S2068). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of ICAD's regulatory filings.

ICAD Stock analysis

ICAD ICAD Inc is a leading company in medical imaging and automated image processing. It was founded in 1984 and is headquartered in Nashua, New Hampshire, USA.